Skip to main content

Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)

Publication ,  Conference
Darrah, JM; Varadarajan, I; Mehta, A; Saultz, JN; McKinney, M; Ghosh, M; Gergis, U; Bende, G; Kasar, S; Hupf, B; Chen, S; Sellner, L; Karmali, R
Published in: Blood
November 5, 2024

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 5, 2024

Volume

144

Issue

Supplement 1

Start / End Page

95 / 95

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Darrah, J. M., Varadarajan, I., Mehta, A., Saultz, J. N., McKinney, M., Ghosh, M., … Karmali, R. (2024). Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL). In Blood (Vol. 144, pp. 95–95). American Society of Hematology. https://doi.org/10.1182/blood-2024-194807
Darrah, Justin M., Indumathy Varadarajan, Amitkumar Mehta, Jennifer N. Saultz, Matthew McKinney, Monalisa Ghosh, Usama Gergis, et al. “Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL).” In Blood, 144:95–95. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-194807.
Darrah JM, Varadarajan I, Mehta A, Saultz JN, McKinney M, Ghosh M, et al. Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL). In: Blood. American Society of Hematology; 2024. p. 95–95.
Darrah, Justin M., et al. “Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL).” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 95–95. Crossref, doi:10.1182/blood-2024-194807.
Darrah JM, Varadarajan I, Mehta A, Saultz JN, McKinney M, Ghosh M, Gergis U, Bende G, Kasar S, Hupf B, Chen S, Sellner L, Karmali R. Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL). Blood. American Society of Hematology; 2024. p. 95–95.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 5, 2024

Volume

144

Issue

Supplement 1

Start / End Page

95 / 95

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology